General Information
As of 05/25/2012
|
| NAV |
$76.54 |
| NAV Daily Change |
$0.24 |
| % Yield |
.57 |
| % SEC Yield |
N/A |
| % YTD Return (as of 04/30/2012) |
18.42 |
| Objective* |
Equity - Sector Health |
| Peer* |
HL MG |
* Key
Portfolio Statistics
|
| % Unrealized Gain YTD |
-2.91 |
| Net Assets (Mil $) N/A |
351.78 |
| % Turnover N/A |
235.14 |
Fees
|
| % Max Sales Load |
5.75 |
| % Min Sales Load |
.00 |
| % Max Deferred Load |
.00 |
Expenses
|
| % Max 12b-1 Fee |
.29 |
| % Max Management Fee |
.53 |
| % Redemption Fee |
.00 |
| % Expense Ratio |
1.28 |
Allocation
|
| Large Growth |
.00 |
| Large Value |
.00 |
| Small Growth |
35.53 |
| Small Value |
.00 |
| Foreign Stock |
.00 |
| Emerging Market |
.00 |
| Precious Metals |
.00 |
| Intermediate Bond |
23.09 |
| Foreign Bond |
.00 |
| High Yield Bond |
.00 |
Portfolio Information |
| Composition |
| As of N/A |
% of Net Assets |
| Stock |
96.44 |
| Cash |
9.24 |
| Bonds |
.00 |
| Preferred |
1.16 |
| Convertibles |
.00 |
| Foreign Stock |
4.13 |
| Foreign Bonds |
.00 |
| Hedge |
.00 |
| Other |
-6.84 |
Sector / Country Weightings
|
| As of 01/31/2012 |
% of Portfolio |
| Health |
54.75 |
| Services |
18.80 |
| Industrial Cyclical |
11.40 |
| Other |
9.23 |
| Technology |
3.34 |
| Retail Trade |
1.36 |
| Non-Durable |
1.12 |
| N/A |
N/A |
| N/A |
N/A |
Portfolio Holdings |
Top Equity Holdings
(As of 01/31/2012) |
% of Portfolio |
Value (Mil$) |
|
| GILEAD SCIENCES INC |
8.68 |
37.27 |
| CELGENE CORP |
8.66 |
37.19 |
| AMGEN INC |
6.85 |
29.45 |
| BIOGEN IDEC INC |
6.38 |
27.42 |
| ALEXION PHARMACEUTICALS INC |
4.80 |
20.61 |
| ILLUMINA INC |
3.34 |
14.37 |
| SALIX PHARMACEUTICALS LTD |
2.83 |
12.16 |
| QUESTCOR PHARMACEUTICALS |
2.74 |
11.78 |
| INTERMUNE INC |
2.54 |
10.93 |
| N/A |
N/A |
N/A |
|
|
This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Funds over the next 6 months.
| Zacks Rank |
Definition |
| #1 |
Strong Buy |
| #2 |
Buy |
| #3 |
Hold |
| #4 |
Sell |
| #5 |
Strong Sell |
| S&P |
500 |
Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank
Zacks Premium Research
|
Zacks Mutual Fund Rank
|
| |
Find similar funds that have a Mutual Fund Rank.
Find Similar Funds Now  |
Fund Description
|
The fund was incepted in September 1997 and is managed by Franklin Advisers. The objective of this fund is to seek capital appreciation. The fund invests at least 80% of its net assets in equity securities of biotechnology companies and discovery research firms worldwide, including therapeutics, drug delivery, gene therapy and other select medical companies. The fund invests a substantial portion of its assets in equity securities of smaller capitalization companies, which are generally companies with a market capitalization of less than $1.5 billion at the time of the fund's investment, and invests a small portion of its assets in private or illiquid securities, such as late stage venture capital financings. The fund offers dividends and capital gains annually. There is no guarantee that fund would regularly pay either income dividends or capital gains distributions.
|
Zacks Commentary for FBDIX
|
|
|
|
Stock Holding Statistics
% of Net Assets
|
| As Of |
N/A |
| Total Issues |
71 |
| Avg. P/E |
44.28 |
| Avg. P/Book |
5.86 |
| Avg. EPS Growth |
15.5 |
| Avg. Market Value (Mil $) |
16,251 |
Risk
|
|
3 Year |
5 Year |
10 Year |
| Beta |
0.94 |
0.72 |
0.79 |
| Alpha |
3.03 |
5.56 |
3.83 |
| R Squared |
0.63 |
0.49 |
0.45 |
| Std. Dev. |
18.49 |
19.75 |
18.86 |
| Sharpe |
1.23 |
0.30 |
3.00 |
Shareholder Information
|
| Manager |
Evan McCulloch |
| Since |
09/97 |
| Manager Rating * SEE EXPLANTION |
.7 |
| Inception Date |
09/15/1997 |
| Shareholders |
0 |
| Dividends Paid |
A |
| Minimum Initial Investment |
$1,000 |
| Minimum Subsequent Investment |
$0 |
| IRA Minimum |
$250 |
| IRA Available |
Y |
Check Writing |
N |
Phone Invest |
Y |
| Phone Exchange |
Y |
Phone Redeem |
Y |
Auto Invest |
Y |
| Wire Redeem |
Y |
Wire Fee |
Y |
Wire Transfer |
Y |
Contact Information
|
| Family |
Franklin/Temp |
| Address |
One Franklin Pkwy
San Mateo, CA 94403 |
| Phone |
800 632-2301 |
|
Sponsored Links 
